Cargando…

Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report

INTRODUCTION: Treatment of cryptorchidism includes hormonal therapy and/or operative methods. To evaluate effectiveness of neoadjuvant hCG-therapy in cryptorchid boys regarding testicle position before and after treatment. MATERIAL AND METHODS: 204 boys with 229 UDT, median age at presentation 6,6 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Kucharski, Piotr, Niedzielski, Jerzy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Polish Urological Association 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936151/
https://www.ncbi.nlm.nih.gov/pubmed/24579035
http://dx.doi.org/10.5173/ceju.2013.02.art29
_version_ 1782305278711037952
author Kucharski, Piotr
Niedzielski, Jerzy
author_facet Kucharski, Piotr
Niedzielski, Jerzy
author_sort Kucharski, Piotr
collection PubMed
description INTRODUCTION: Treatment of cryptorchidism includes hormonal therapy and/or operative methods. To evaluate effectiveness of neoadjuvant hCG-therapy in cryptorchid boys regarding testicle position before and after treatment. MATERIAL AND METHODS: 204 boys with 229 UDT, median age at presentation 6,6 years, SD ±3.4; 179 (87.7%) with unilateral and 25 (12.3%) with bilateral defect were treated between 1994 and 2008. 103 boys (119 gonads – 51.9%) underwent orchiopexy alone, while 101 boys (110 gonads – 48.1%) neoadjuvant hCG-therapy. The testicle position was evaluated before and one year after therapy. Every patient was seen in our outpatient department 2 to 16 years after the therapy. RESULTS: Out of 110 testes of 101 boys after hCG-therapy, 49 testicles (44.5%) descended to the scrotum and these 44 patients were not qualified for orchiopexy. Remaining 61 testes (55.5%) did not reach the scrotum after hormonal therapy and these 57 boys underwent orchiopexy. Gonadotropin induced the descent of 90 out of 110 testicles at least one level down, therefore overall effectiveness of hCG therapy was 81.8% (chi = 29.778, p = 0.000). 49 out of 110 UDT descended to the scrotum (44.5%). The efficacy of hormonal treatment did not depended on initial position of UDT (p = 0.43, p = 0.04, p = 0.97). We performed only 7 orchidectomies of disgenetic testes (3.1%). Neither type of treatment nor initial position of testicle influenced the future gonad atrophy (p = 0.5, p = 0.979). CONCLUSIONS: Neoadjuvant hCG-therapy induced descent to the scrotum of 44.5% UDT and improved position of testis before orchidopexy in further 37.3% of patients.
format Online
Article
Text
id pubmed-3936151
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Polish Urological Association
record_format MEDLINE/PubMed
spelling pubmed-39361512014-02-26 Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report Kucharski, Piotr Niedzielski, Jerzy Cent European J Urol Original Paper INTRODUCTION: Treatment of cryptorchidism includes hormonal therapy and/or operative methods. To evaluate effectiveness of neoadjuvant hCG-therapy in cryptorchid boys regarding testicle position before and after treatment. MATERIAL AND METHODS: 204 boys with 229 UDT, median age at presentation 6,6 years, SD ±3.4; 179 (87.7%) with unilateral and 25 (12.3%) with bilateral defect were treated between 1994 and 2008. 103 boys (119 gonads – 51.9%) underwent orchiopexy alone, while 101 boys (110 gonads – 48.1%) neoadjuvant hCG-therapy. The testicle position was evaluated before and one year after therapy. Every patient was seen in our outpatient department 2 to 16 years after the therapy. RESULTS: Out of 110 testes of 101 boys after hCG-therapy, 49 testicles (44.5%) descended to the scrotum and these 44 patients were not qualified for orchiopexy. Remaining 61 testes (55.5%) did not reach the scrotum after hormonal therapy and these 57 boys underwent orchiopexy. Gonadotropin induced the descent of 90 out of 110 testicles at least one level down, therefore overall effectiveness of hCG therapy was 81.8% (chi = 29.778, p = 0.000). 49 out of 110 UDT descended to the scrotum (44.5%). The efficacy of hormonal treatment did not depended on initial position of UDT (p = 0.43, p = 0.04, p = 0.97). We performed only 7 orchidectomies of disgenetic testes (3.1%). Neither type of treatment nor initial position of testicle influenced the future gonad atrophy (p = 0.5, p = 0.979). CONCLUSIONS: Neoadjuvant hCG-therapy induced descent to the scrotum of 44.5% UDT and improved position of testis before orchidopexy in further 37.3% of patients. Polish Urological Association 2013-08-13 2013 /pmc/articles/PMC3936151/ /pubmed/24579035 http://dx.doi.org/10.5173/ceju.2013.02.art29 Text en Copyright by Polish Urological Association http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Kucharski, Piotr
Niedzielski, Jerzy
Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report
title Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report
title_full Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report
title_fullStr Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report
title_full_unstemmed Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report
title_short Neoadjuvant human Chorionic Gonadotropin (hCG) therapy may improve the position of undescended testis: a preliminary report
title_sort neoadjuvant human chorionic gonadotropin (hcg) therapy may improve the position of undescended testis: a preliminary report
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936151/
https://www.ncbi.nlm.nih.gov/pubmed/24579035
http://dx.doi.org/10.5173/ceju.2013.02.art29
work_keys_str_mv AT kucharskipiotr neoadjuvanthumanchorionicgonadotropinhcgtherapymayimprovethepositionofundescendedtestisapreliminaryreport
AT niedzielskijerzy neoadjuvanthumanchorionicgonadotropinhcgtherapymayimprovethepositionofundescendedtestisapreliminaryreport